Molecular Interactions of Viral Insulin/IGF-like Peptides with Zebrafish Receptors

This study utilizes all-atom molecular dynamics simulations and free energy calculations to characterize the binding interactions of viral insulin/IGF-like peptides with zebrafish receptors, revealing both conserved binding modes with human systems and unique residue-specific interactions that suggest potential strategies for enhancing peptide binding affinity through mutation.

The Gist

The Big Picture: Viral Imposters and Fish Keys

Imagine your body has a sophisticated security system. To get inside your cells and tell them to grow or eat sugar, you need a specific key (a hormone like Insulin or IGF1) to turn a specific lock (a receptor on the cell surface). If the key doesn't fit perfectly, the door stays shut, leading to problems like diabetes or cancer.

Now, imagine a virus is a master thief. Instead of just breaking the door down, it has learned to fake a key. These viruses, which infect fish, have evolved to make their own "fake keys" called Viral Insulin/IGF-like Peptides (VILPs). These viral keys look and act so much like the fish's real keys that they can trick the fish's locks into opening. This helps the virus hijack the fish's cells to reproduce.

The Problem: Scientists know a lot about how these viral keys work on human locks. But these viruses live in fish! We didn't know exactly how these viral keys fit into the fish locks. Did they fit perfectly? Did they wiggle around? Could we tweak the viral keys to make them even better (or worse) at opening the door?

The Solution: The authors of this paper used powerful computer simulations (like a high-tech movie maker) to watch these viral keys and fish locks interact in real-time, atom by atom. They compared the viral keys to the fish's natural keys to see what makes them tick.

---

The Experiment: A Digital Dance Floor

Think of the computer simulation as a digital dance floor.

1. The Dancers: The researchers created digital models of four dancers:

   • The Real Fish Keys: Zebrafish Insulin and Zebrafish IGF1 (the natural keys).
   • The Viral Imposters: Two types of viral keys (one is a single piece, the other is two pieces linked together).
   • The Locks: The Zebrafish Insulin Receptor and the IGF1 Receptor.

2. The Dance: They watched these dancers for a long time (simulating microseconds of time) to see how they moved.

   • Unbound State: How do the keys move when they are just floating alone?
   • Bound State: How do they move when they grab onto the lock?

3. The Energy Score: They calculated an "energy score" for every part of the key. This tells us which parts of the key are doing the heavy lifting to hold onto the lock, and which parts are just along for the ride.

---

What They Found: The Good, The Bad, and The "Almost"

1. The Viral Keys are Flexible (But Stable)

When the viral keys were floating alone, they were a bit wobbly, especially at their "tails" (the ends of the molecule). However, once they grabbed onto the fish lock, they became much more rigid and stable. It's like a loose-fitting jacket that suddenly snaps perfectly into place when you put it on.

• Exception: The natural fish insulin was a bit of a rebel. When it grabbed the lock, it actually got more wiggly at the end, suggesting it has a unique way of locking in.

2. The "Key Fit" is Mostly the Same

Most of the time, the viral keys fit the fish locks in the exact same way human keys fit human locks. The main "gripping" parts of the key (called Site 1) are conserved. This means the virus is a very good mimic; it copied the design so well that the fish lock doesn't immediately notice the difference.

3. The Viral Keys Have "Secret Weapons" (Unique Interactions)

Here is the cool part. While the viral keys look like the real ones, they have a few non-conserved residues (specific amino acids) that are different.

• The Viral Advantage: Some of these differences actually helped the viral keys hold on tighter to the fish lock than the natural fish keys did in some cases.
• The Natural Advantage: In other spots, the natural fish keys had better "grip" because they had larger, stickier, or more hydrophobic (water-repelling) parts that fit deeper into the lock's grooves.

Analogy: Imagine the lock has a groove. The natural key has a big, fat rubber bump that fits perfectly. The viral key has a slightly smaller, smoother plastic bump. Sometimes the rubber bump holds tighter; sometimes the plastic bump slides in easier and holds just as well.

4. The "Recipe for Improvement"

The most exciting finding is that the researchers identified specific spots on the viral keys where they could swap out a "plastic bump" for a "rubber bump" (or vice versa).

• They found that if you took the viral key and changed a few specific letters in its code to match the natural fish key, the viral key might become an even stronger binder.
• Conversely, they found spots where the natural fish key was superior, suggesting that if we want to design new drugs, we should look at those natural "super-grip" spots.

---

Why Does This Matter? (The "So What?")

This isn't just about fish and viruses. It's about designing better medicine.

1. Understanding Disease: By understanding how these viral imposters trick the fish, we learn more about how the insulin system works in general.
2. Drug Design: The researchers essentially created a "cheat sheet" for engineers. They showed exactly which parts of a molecule are responsible for a strong grip.
   • If we want to make a super-strong insulin drug for humans, we can look at these viral keys and the fish keys, see which parts are doing the best work, and mix and match them to create a "super-key" that works better than anything nature made.
3. Evolutionary Insight: It shows how viruses are master engineers, constantly evolving to mimic our biology so perfectly that they can hijack our systems.

The Bottom Line

The paper is like a molecular detective story. The scientists used computer simulations to watch viral keys try to open fish locks. They discovered that while the viruses are great mimics, they have a few unique tricks up their sleeves. By studying these tricks, we can learn how to build better keys (drugs) to fix broken locks (diseases like diabetes) in humans.

Technical Summary

1. Problem Statement

Viral insulin/IGF-like peptides (VILPs), produced by viruses in the Iridoviridae family that infect fish, mimic host insulin and insulin-like growth factor 1 (IGF1). These peptides can bind to and activate insulin receptors (IR) and IGF1 receptors (IGF1R), potentially manipulating host metabolism to facilitate viral replication. While the structural interactions of VILPs with human receptors have been partially mapped, there is a significant knowledge gap regarding their interactions with receptors in their natural host organisms (fish). Understanding these interactions is crucial for deciphering viral pathogenesis and for utilizing VILPs as templates for designing novel therapeutics with enhanced binding affinities.

2. Methodology

The authors employed a comprehensive computational approach combining homology modeling and all-atom Molecular Dynamics (MD) simulations:

• Structural Modeling:
  • Generated structural models for two viral peptides: GIV-dcVILP (double-chain, analogous to insulin) and GIV-scVILP (single-chain, analogous to IGF1) derived from the Grouper Iridovirus (GIV).
  • Generated models for native Zebrafish Insulin (Zeb Ins) and Zebrafish IGF1 (Zeb IGF1).
  • Modeled the receptors: truncated Zebrafish IR (Zeb µIR) and Zebrafish IGF1R (Zeb µIGF1R).
  • Models were built using MODELLER based on human templates (PDB: 6PXV for Insulin/IR, 6PYH for IGF1/IGF1R) and refined using the ff19SB force field.
• Molecular Dynamics (MD) Simulations:
  • Performed all-atom MD simulations (using AMBER software) for both unbound peptides and peptide-receptor complexes.
  • Simulation Duration: 500 ns for unbound peptides (3 independent runs); 2000 ns for peptide-receptor complexes (2 independent runs).
  • Conditions: NPT ensemble at 300 K and 1 atm, with explicit OPC water and 150 mM NaCl.
• Free Energy Calculations:
  • Applied the MM/GBSA (Molecular Mechanics/Generalized Born Surface Area) method to calculate binding free energies ($\Delta G_{bind}$).
  • Conducted per-residue free energy decomposition to identify specific amino acids contributing most significantly to binding.
  • Calculated $\Delta\Delta G_{bind}$ to compare energetic contributions between viral peptides and their native zebrafish counterparts.

3. Key Contributions

• First Comprehensive MD Study of VILPs in Host Receptors: This work provides the first detailed atomic-level analysis of how viral insulin-like peptides interact with their natural host (zebrafish) receptors, contrasting them with human receptor interactions.
• Residue-Level Energetic Mapping: The study identifies specific non-conserved residues in VILPs that drive unique binding interactions, distinguishing them from native ligands.
• Rational Mutagenesis Targets: The authors propose specific point mutations in VILPs (mimicking conserved human/zebrafish residues) that could theoretically enhance binding affinity, offering a roadmap for engineering improved peptide therapeutics.

4. Key Results

A. Conformational Stability

• Unbound State: All peptides maintained their canonical folds (stabilized by disulfide bonds). Single-chain peptides (scVILP, Zeb IGF1) showed high flexibility in the C-domain, while double-chain peptides (dcVILP, Zeb Ins) showed flexibility primarily in the C-terminal residues of the B-chain.
• Bound State: Receptor binding generally stabilized the peptides, reducing overall flexibility (RMSD). However, Zeb Ins exhibited increased flexibility in the B-chain C-terminus upon binding, whereas viral peptides (GIV-dcVILP, GIV-scVILP) became more rigid.

B. Binding Affinity and Energetics

• Overall Affinity:
  • Zeb IGF1 showed the strongest binding to Zeb µIGF1R ($\Delta G_{bind} \approx -89.4$ kcal/mol).
  • GIV-scVILP bound less strongly ($\approx -73.8$ kcal/mol).
  • GIV-dcVILP bound more strongly to Zeb µIR ($\approx -52.5$ kcal/mol) than native Zeb Ins ($\approx -34.7$ kcal/mol).
• Domain Contributions: In both viral peptides, the B-domain/B-chain contributed significantly more to the binding energy than the A-domain/A-chain, consistent with experimental data on IGF1R binding.

C. Specific Residue Interactions & Mutagenesis Opportunities

The study identified specific residue substitutions that explain differences in binding affinity:

• Double-Chain Peptides (Insulin-like):

  • GIV-dcVILP vs. Zeb Ins: GIV-dcVILP had stronger interactions due to IleB12 (more hydrophobic than Zeb Ins's ValB12) and ArgB29 (forming multiple salt bridges vs. Zeb Ins's LysB29).
  • Weaknesses in GIV-dcVILP: TyrB25 and ThrB26 in the virus were less favorable than PheB25 and TyrB26 in Zeb Ins due to lower hydrophobicity and shallower insertion into the receptor pocket.
  • Proposal: Mutating TyrB25 $\to$ Phe and ThrB26 $\to$ Tyr in GIV-dcVILP could enhance affinity.

• Single-Chain Peptides (IGF1-like):

  • GIV-scVILP vs. Zeb IGF1: Zeb IGF1 had stronger binding due to Phe23 and Phe25 (aromatic/hydrophobic) interacting deeply with the receptor, compared to Val24 and Thr26 in the virus.
  • Weaknesses in GIV-scVILP: Asp54 (shorter sidechain) interacted less effectively than Glu58 in Zeb IGF1.
  • Strengths in GIV-scVILP: Arg30 in the virus was more favorable than Thr29 in Zeb IGF1 due to a longer, positively charged sidechain.
  • Proposal: Mutating Val24 $\to$ Phe, Thr26 $\to$ Phe, and Asp54 $\to$ Glu in GIV-scVILP could improve binding.

5. Significance

• Therapeutic Design: The findings provide a structural basis for engineering VILP-based therapeutics. By identifying specific residues that limit viral peptide affinity, researchers can design "super-binders" or optimized analogs for treating diabetes or cancer by targeting the IR/IGF1R axis with higher specificity.
• Viral Pathogenesis: The study elucidates how fish viruses manipulate host signaling pathways, highlighting the evolutionary adaptation of VILPs to bind host receptors effectively despite sequence divergence.
• Methodological Validation: The work validates the use of MD simulations and MM/GBSA for predicting binding energetics in non-human systems where experimental structures are scarce, bridging the gap between viral biology and structural pharmacology.

In conclusion, this paper demonstrates that while VILPs share core binding modes with native ligands, specific non-conserved residues dictate their unique energetic profiles. Targeting these residues offers a viable strategy for enhancing the therapeutic potential of viral insulin mimics.